Literature DB >> 20674312

Risk for cardiovascular events in an Italian population of patients with type 2 diabetes.

E Pellegrini1, M Maurantonio, I M Giannico, M S Simonini, D Ganazzi, L Carulli, R D'Amico, A Baldini, P Loria, M Bertolotti, N Carulli.   

Abstract

BACKGROUND AND AIM: This study aims to analyse the risk of cardiovascular events in a local cohort of patients with type 2 diabetes, and to evaluate the prognostic accuracy of four algorithms used to estimate cardiovascular risk: the Framingham study, United Kingdom Prospective Diabetes Study (UKPDS), Riskard study and Progetto Cuore. METHOD AND
RESULTS: We analysed clinical charts of the Diabetes Clinics of Modena for the period 1991-95. Patients in the age range of 35-65 with type 2 diabetes and no previous cardiovascular disease were eligible. The incidence of new cardiovascular disease was compared with estimated rates deriving from the different functions. A stratification was obtained in subgroups at different cardiovascular risk, allowing comparison between the algorithms. A total of 1532 patients were eligible; women presented a worse cardiovascular risk profile. An absolute 10-year rate of cardiovascular events of 14.9% was observed. Comparing patients with events with event-free subjects, we found significant differences in systolic blood pressure, age at visit, smoking, high-density lipoprotein (HDL)-cholesterol, duration of diabetes, glycosylated haemoglobin (HbA1c) and co-morbidities. Comparing the estimated risk rate according to the different functions, Italian algorithms were more consistent with observed data; however, Progetto Cuore and Riskard show underestimation of events when applied to females.
CONCLUSIONS: Estimation of cardiovascular risk is dependent on the algorithm adopted and on the baseline risk of the reference cohort. Functions designed for a specific population, including risk variables peculiar for diabetes, should be adopted to increase the performance of such functions which is clearly unsatisfactory at present.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674312     DOI: 10.1016/j.numecd.2010.02.022

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  2 in total

1.  Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study.

Authors:  Marco Bertolotti; Carlotta Franchi; Marco B L Rocchi; Andrea Miceli; M Vittoria Libbra; Alessandro Nobili; Giulia Lancellotti; Lucia Carulli; Chiara Mussi
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

2.  Dietary compliance, dietary supplementation and traditional remedy usage of type 2 diabetic patients with and without cardiovascular disease.

Authors:  Mun Chieng Tan; Ooi Chuan Ng; Teck Wee Wong; Anthony Joseph; Abdul Rahman Hejar; Abdul Aziz Rushdan
Journal:  Clin Nutr Res       Date:  2014-12-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.